蛋白质定序市场规模、份额、成长分析、按产品、按应用、按最终用户、按地区 - 行业预测，2025-2032 年

2023年蛋白质定序市场规模为13.4亿美元，从2024年的13.9亿美元成长到2032年的17.5亿美元，复合年增长率预计为3.5%。

由于其在从头定序（透过质谱解码氨基酸序列）中的重要作用，蛋白质定序市场正在经历强劲成长。这种高通量蛋白质体学技术在基于目标的药物发现中越来越受到关注，这在很大程度上是由于生物技术和製药公司专注于在已开发和新兴市场开发标靶治疗。蛋白质体学研究资金的增加反映了药物开发中对蛋白质生物标记物不断增长的需求，进一步加强了该领域的发展。随着製药和生物技术行业越来越多地采用基于目标的药物设计，该市场预计将继续成长。此外，蛋白质定序技术的进步和正在进行的基因改造生物研究可能会增强基因工程的应用并推动该行业的未来成长。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制因素和挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析
• 技术进步
• 监管环境
• 专利分析
• 案例研究

蛋白质定序市场规模：依产品/服务划分

• 市场概况
• 蛋白质定序产品
  • 试剂/耗材
  • 装置
  • 质谱分析
  • 艾德曼劣化
  • 软体
• 蛋白质定序服务
  • 样品製备服务
  • 定序服务
  • 资料分析服务

蛋白质定序市场规模：依应用分类

• 市场概况
• 生物标记发现
• 蛋白质工程研究
• 生物製药
• 其他的
  • 结构生物学
  • 药物发现

蛋白质定序市场规模：依最终用户划分

• 市场概况
• 製药和生物技术公司
• 研究中心
• 学术机构
• 其他的
  • 合约研究组织（CRO）
  • 诊断实验室

蛋白质定序市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2022-2024）

主要企业简介

• Thermo Fisher Scientific Inc.（USA）
• Agilent Technologies, Inc.（USA）
• Bioinformatics Solutions Inc.（Canada）
• Shimadzu Corporation（Japan）
• Waters Corporation（USA）
• Bruker Corporation（USA）
• Danaher Corporation（USA）
• PerkinElmer, Inc.（USA）
• Charles River Laboratories International, Inc.（USA）
• QIAGEN NV（Netherlands）
• Merck KGaA（Germany）
• GenScript Biotech Corporation（China）
• Creative Proteomics（USA）
• Bio-Rad Laboratories, Inc.（USA）
• Promega Corporation（USA）
• Pacific Biosciences of California, Inc.（USA）
• Oxford Nanopore Technologies Ltd.（UK）
• Illumina, Inc.（USA）
• Becton, Dickinson and Company（USA）
• Eurofins Scientific（Luxembourg）

结论和建议

Protein Sequencing Market size was valued at USD 1.34 Billion in 2023 and is poised to grow from USD 1.39 Billion in 2024 to USD 1.75 Billion by 2032, growing at a CAGR of 3.5% during the forecast period (2025-2032).

The protein sequencing market is experiencing robust growth, driven by its vital role in de novo sequencing, which deciphers amino acid sequences via mass spectrometry. This high-throughput proteomic technique has gained traction in target-based drug discovery, significantly influenced by the intensified focus of biotechnology and pharmaceutical companies on developing targeted therapies across developed and emerging markets. Increased funding for proteomics research further bolsters this sector, reflecting a heightened demand for protein biomarkers in drug development. As the pharmaceutical and biotechnology industries increasingly adopt target-based medication design, the market is poised for continued expansion. Moreover, advancements in protein sequencing technology and ongoing research into genetically modified organisms will likely enhance its application in genetic engineering, propelling future growth in the industry.

Top-down and bottom-up approaches were used to estimate and validate the size of the Protein Sequencing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Protein Sequencing Market Segmental Analysis

Global Protein Sequencing Market is segmented by product, application, end-user and region. Based on product, the market is segmented into protein sequencing products and protein sequencing services. Based on application, the market is segmented into biomarker discovery, protein engineering studies, biotherapeutics and others. Based on end-user, the market is segmented into pharmaceutical & biotechnology companies, research centers, academic institutions and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Protein Sequencing Market

The Protein Sequencing market is set to experience significant growth driven by several technological advancements. Key among these is the enhancement of clinical mass spectrometry and analytical techniques, which are expected to facilitate more accurate and efficient protein analysis. Additionally, the increasing financial support from both public and private sectors for proteome research is anticipated to significantly contribute to the expansion of this market. This combination of improved technologies and bolstered funding will likely create a favorable environment for innovation and development within the protein sequencing sector, thus propelling market growth throughout the forecast period.

Restraints in the Protein Sequencing Market

One of the significant challenges hindering the growth of the Protein Sequencing market is the high cost associated with the necessary infrastructure. This financial burden poses a considerable barrier to market expansion during the forecast period. Furthermore, the demand for highly skilled researchers and laboratory personnel also restricts growth potential, as specialized expertise is essential for effective protein sequencing. Additionally, the complexities involved in generating pure protein samples contribute to the overall limitations facing the market. Collectively, these factors create a restrictive environment that may slow down advancements and innovation within the Protein Sequencing landscape.

Market Trends of the Protein Sequencing Market

The protein sequencing market is experiencing significant growth driven by advancements in protein engineering, particularly the incorporation of unnatural amino acids (uAA). This trend enables site-specific conjugation of functional moieties, enhancing the effectiveness of therapeutic drugs, including antibodies and vaccines. As bioformulations dominate the pharmaceutical landscape, the demand for precise and efficient protein characterization tools is surging. Furthermore, innovations in post-translational engineering and strain development are accelerating biopharmaceutical approvals, making the market more dynamic. With a focus on developing better-defined protein products, the protein sequencing market is poised for substantial expansion in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Case Studies

Global Protein Sequencing Market Size by Product & Service & CAGR (2025-2032)

• Market Overview
• Protein Sequencing Products
  • Reagents & Consumables
  • Instruments
  • Mass Spectrometry
  • Edman Degradation
  • Software
• Protein Sequencing Services
  • Sample Preparation Services
  • Sequencing Services
  • Data Analysis Services

Global Protein Sequencing Market Size by Application & CAGR (2025-2032)

• Market Overview
• Biomarker Discovery
• Protein Engineering Studies
• Biotherapeutics
• Others
  • Structural Biology
  • Drug Discovery

Global Protein Sequencing Market Size by End-User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Research Centers
• Academic Institutions
• Others
  • Contract Research Organizations (CROs)
  • Diagnostic Laboratories

Global Protein Sequencing Market Size & CAGR (2025-2032)

• North America (Product & Service, Application, End-User)
  • US
  • Canada
• Europe (Product & Service, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Service, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Service, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Service, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioinformatics Solutions Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shimadzu Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Waters Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories International, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenScript Biotech Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Proteomics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific Biosciences of California, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations